Table 1:

Group difference in the DTI measurement between the patients with HCP and the controls

No.SourcedfFAMDADRD
SSF ValuePaSSF ValuePaSSF ValuePaSSF ValuePa
gCC30Group,10.08314.43.00250.2317.13.00120.0371.6NS0.50614.35.0025
age,10.18431.73<.00010.51538.26<.00010.0974.16NS0.43312.28.0041
scanner20.0252.19NS0.0250.94NS0.0781.67NS0.0260.37NS
sCC26Group,10.05816.64.00170.0795.42.060.0010.02NS0.18315.08.0025
age,10.257.69<.00010.9867.25<.00010.5610.98.00751.265104.23<.0001
scanner20.0050.73NS0.0772.64NS0.1371.34NS0.0783.23NS
ALIC31Group,10.025.43.0580.0071.29NS0.07612.48.0040.0000.00NS
age,10.14339.54<.00010.49588.83<.00010.28547.04<.00010.62268.15<.0001
scanner20.0020.31NS0.0181.63NS0.0151.28NS0.0111.2NS
PLIC31Group,10.0070.7NS0.0183.06NS0.1029.74.00960.000.01NS
age,10.12612.4.0040.32755.77<.00010.16615.74.00170.41531.44<.0001
scanner20.0020.12NS0.0141.2NS0.052.36NS0.0030.11NS
  • Note:—No. indicates number of observations; SS, sum of squares (type II); NS, not significant; HCP, hydrocephalus; df, degrees of freedom.

  • a All P values are adjusted for multiple testing using a false discovery rate method.